FDA MedWatch - UPDATE: Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems
U.S. Food and Drug Administration sent this bulletin at 02/03/2026 12:28 PM EST
If your email program has trouble displaying this email, view as a webpage.
UPDATE: Risk of False Positive Lead Test Results with Certain Capillary Blood Collection Tubes Used with Magellan Diagnostics LeadCare Testing Systems – FDA Safety Communication